Papers
1
Total Citations
6
H-Index
1
About
Yangyi Liu is a pioneering researcher at the intersection of robotics, mechanobiology, and cancer therapy. Their most cited work, "Robotic Actuation‐Mediated Quantitative Mechanogenetics for Noninvasive and On‐Demand Cancer Therapy" (2024), introduces a groundbreaking approach that replaces traditional high-power ultrasound with precise, robotic actuation to trigger mechanogenetic signals for targeted cancer treatment. This innovation offers a noninvasive, on-demand therapeutic modality with reduced side effects, addressing a critical limitation in current physiotherapy. Although early in its citation trajectory, this work has already garnered 6 citations, signaling strong interest from the biomedical engineering and oncology communities. Liu’s research fundamentally advances the field of mechanogenetics by enabling quantitative control over cellular mechanical forces, opening new avenues for smart, robotic-assisted therapies. Their work stands at the forefront of integrating soft robotics with genetic engineering, promising safer and more precise interventions for solid tumors. As a rising leader in this niche, Yangyi Liu is shaping the future of noninvasive cancer treatment through interdisciplinary innovation.
Research Focus
Key Achievements
Top Papers
- 1